MS Dhoni named brand ambassador of Emcure Pharmaceuticals

PTI : New Delhi, Tue Mar 12 2013, 22:08 hrs

Ads by Google

Top Stories

Indian cricket captain Mahendra Singh Dhoni, has been signed as the brand ambassador of Emcure Pharmaceuticals, a company that specialises in tablets, capsules, injectables and Onco products.

The company has its presence in across Asia, Africa, CIS, Europe, Latin America and Middle East.

The 31-year-old Dhoni, who has been endorsing various products from beverages to motorbikes and FMCG products, felt that it was his duty to create awareness towards various illnesses and their cures.

Emcure was the natural choice for the wicket-keeper batsman given their vision for the healthcare industry.

Emcure, established in 1983, began with a single manufacturing facility at its headquarter in Pune and has grown into one of the biggest pharmaceutical corporate in the country.

Ads by Google

ALSO READ

Mayweather (L) connects against Robert Guerrero in their welterweight title fight. Mayweather, who last lost a bout in the semifinals of the 1996 Olympics, improved his pro record to 44-0. REUTERS

Mayweather too hot

IPL 2013: It's going to be tough game against Punjab, says Daniel Vettori

Rajasthan Royals' Rahul Dravid and A Rahane take runs against Pune Warriors during an IPL 6 match in Jaipur on Sunday . PTI Photo

IPL 2013: Ajinkya Rahane, Rahul Dravid fashion Rajasthan Royals' win

IPL 2013: A forgettable 'hat-trick' for Kieron Pollard

Please read our terms of use before posting comments

TERMS OF USE: The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).